Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation

Desai S, Ayres E, Bak H, Manco M, Lynch S, Raab S, Du A, Green D, Skobowiat C, Wangari-Talbot J, Zheng Q.

J Drugs Dermatol. 2019 May 1;18(5):454-459.

PMID:
31141852
2.

Photoaging and Photoprotection in United States Hispanic Population

Zheng Q, Wangari-Talbot J, Bouez C, Verschoore M.

J Drugs Dermatol. 2019 Mar 1;18(3s):s121-123.

PMID:
30909358
3.

Metabotropic glutamate receptors in cancer.

Yu LJ, Wall BA, Wangari-Talbot J, Chen S.

Neuropharmacology. 2017 Mar 15;115:193-202. doi: 10.1016/j.neuropharm.2016.02.011. Epub 2016 Feb 16. Review.

4.

Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment response.

Domanitskaya N, Wangari-Talbot J, Jacobs J, Peiffer E, Mahdaviyeh Y, Paulose C, Malofeeva E, Foster K, Cai KQ, Zhou Y, Egleston B, Hopper-Borge E.

Br J Cancer. 2014 Aug 12;111(4):696-707. doi: 10.1038/bjc.2014.326. Epub 2014 Jun 17.

5.

Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.

Wangari-Talbot J, Hopper-Borge E.

J Can Res Updates. 2013 Oct 31;2(4):265-282.

6.

Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.

Wall BA, Wangari-Talbot J, Shin SS, Schiff D, Sierra J, Yu LJ, Khan A, Haffty B, Goydos JS, Chen S.

Pigment Cell Melanoma Res. 2014 Mar;27(2):263-74. doi: 10.1111/pcmr.12207. Epub 2014 Jan 22.

7.

Genetics of melanoma.

Wangari-Talbot J, Chen S.

Front Genet. 2013 Jan 25;3:330. doi: 10.3389/fgene.2012.00330. eCollection 2012.

8.

Functional effects of GRM1 suppression in human melanoma cells.

Wangari-Talbot J, Wall BA, Goydos JS, Chen S.

Mol Cancer Res. 2012 Nov;10(11):1440-50. doi: 10.1158/1541-7786.MCR-12-0158. Epub 2012 Jul 13.

9.

Regulation of mGluR1 expression in human melanocytes and melanoma cells.

Lee HJ, Wall BA, Wangari-Talbot J, Chen S.

Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1123-31. doi: 10.1016/j.bbagrm.2012.06.005. Epub 2012 Jul 5.

10.

Glutamate receptors: emerging players in melanomagenesis.

Wangari-Talbot J, Chen S.

Pigment Cell Melanoma Res. 2011 Dec;24(6):1082-3. doi: 10.1111/j.1755-148X.2011.00926.x. No abstract available.

PMID:
22216442
11.

Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.

Lee HJ, Wall BA, Wangari-Talbot J, Shin SS, Rosenberg S, Chan JL, Namkoong J, Goydos JS, Chen S.

Clin Cancer Res. 2011 Nov 15;17(22):7080-92. doi: 10.1158/1078-0432.CCR-11-0098. Epub 2011 Aug 15. Erratum in: Clin Cancer Res. 2012 Mar 1;18(5):1484.

12.

Role of the G Protein-Coupled Receptor, mGlu₁, in Melanoma Development.

Wangari-Talbot J, Goydos J, Chen S.

Pharmaceuticals (Basel). 2010 Aug 26;3(9):2821-2837. Review.

13.

Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development.

Wangari-Talbot J, Goydos J, Chen S.

Pharmaceuticals (Basel). 2010 Aug 26;3(9):2821-2837.

Supplemental Content

Loading ...
Support Center